Yet they also come with hope, something new for Alzheimer’s patients and their families. For now these anti-amyloid therapies are the best pharmaceutical interventions we have on offer. Merriman reached out to his physician after hearing about anti-amyloid therapies and was referred to Heidebrink for evaluation. A year later, however, 80 percent of those surveyed said they were now discussing anti-amyloid therapies with their patients. There also are ongoing trials to determine whether anti-amyloid drugs administered before symptoms emerge can delay or even prevent the onset of Alzheimer’s.